Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy

The past decades have witnessed great progress in cancer immunotherapy, which has profoundly revolutionized oncology, whereas low patient response rates and potential immune‐related adverse events remain major clinical challenges. With the advantages of controlled delivery and modular flexibility, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Shaojun, Xiao, Fengfeng, Chen, Meiwan, Gao, Huile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728817/
https://www.ncbi.nlm.nih.gov/pubmed/34796689
http://dx.doi.org/10.1002/advs.202103836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728817/
https://www.ncbi.nlm.nih.gov/pubmed/34796689
http://dx.doi.org/10.1002/advs.202103836

Ejemplares similares